Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

BIOCRYST PHARMACEUTICALS INC (BCRX)

275 + Investors. Track Smart Money conviction in BCRX. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -11
Streak
2Q ▼
Buyers last Q
46%

Smart Money Signals — BCRX

Based on 260 hedge funds · latest filing: 2025 Q4 · updated quarterly

📉

Selling streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds reduced or closed their BCRX positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
📊

High ownership — 92% of 3.0Y peak

92% of all-time peak
260 funds currently hold this stock — 92% of the 3.0-year high of 284 funds (reached 2025 Q2). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📶

Steady growth — +7% more funds vs a year ago

fund count last 6Q
+16 new funds entered over the past year (+7% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟠

More sellers than buyers — 46% buying

138 buying160 selling
Last quarter: 160 funds reduced or exited vs 138 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
📈

More new buyers each quarter (+13 vs last Q)

new funds entering per quarter
Funds opening a new BCRX position: 44 → 54 → 35 → 48. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

62% of holders stayed for 2+ years

■ 62% conviction (2yr+) ■ 19% medium ■ 18% new
162 out of 260 hedge funds have held BCRX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
📊

Peak discovery — momentum slowing

30 → 44 → 54 → 35 → 48 new funds/Q
New funds entering each quarter: 44 → 54 → 35 → 48. BCRX is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.
🏛️

Deep conviction — 69% of holders stayed 2+ years

■ 69% veterans ■ 11% 1-2yr ■ 20% new
Of 275 current holders: 191 (69%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
✅

Strong quality — 35% AUM from major funds

35% from top-100 AUM funds
38 of 260 holders rank in the top 100 by AUM, accounting for 35% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
3.3
out of 10
Low Exit Risk
Exit risk score 3.3/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Hedge Fund Ownership: BCRX

How many hedge funds hold BCRX — quarterly history vs. share price
Quarterly hedge fund ownership of BCRX vs. share price

Market Analysis: BCRX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: BCRX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Smart Money Signal ?
Broad Consensus, Selective Conviction

Many quality funds hold this stock, but top-tier positions remain relatively small.

44 top-rated funds 2 high-conviction
Consensus
7.2
/ 10
breadth
×
Elite
2.3
/ 10
conviction
Hedge Fund Positioning: BCRX
2026 Q1 Stats Unlock in 10 days 275 + Investors

Track Smart Money conviction in BCRX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 275 278 -1.08%
13F Shares 210M 195M 7.64%
Total Value $1.64B $1.48B 10.43%
New Positions 51 35 +16
Increased Positions 106 107 -1
Closed Positions 59 49 +10
Reduced Positions 110 117 -7
Total Calls 8 4 100.0%
Total Puts 9 4 125.0%
PUT/CALL Ratio 1.12 1.0 Neutral

Statistics: BCRX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

275 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in BCRX. Verified SEC 13F-HR filings.

Top 25 institutional holders of BCRX — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Royalty Pharma Sub-Manager, LLC 17.51% 3,846,154 $30.0M
2 DOLIVER ADVISORS, LP 0.81% 374,328 $3.6M
3 QTR Family Wealth, LLC 0.63% 157,062 $1.5M
4 Counterweight Ventures, LLC 0.51% 95,384 $908K
5 RFG Advisory, LLC 0.50% 2,870,700 $27.3M
6 Cannon Global Investment Management, LLC 0.49% 26,600 $253K
7 Capricorn Fund Managers Ltd 0.30% 202,900 $1.9M
8 Phocas Financial Corp. 0.29% 195,540 $1.9M
9 Hillsdale Investment Management Inc. 0.17% 639,100 $6.1M
10 OP Asset Management Ltd 0.15% 1,252,863 $13.8M
11 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 0.13% 90,977 $866K
12 Candriam S.C.A. 0.11% 2,286,841 $21.8M
13 Leisure Capital Management 0.09% 28,000 $267K
14 Aberdeen Group plc 0.08% 5,040,670 $48.0M
15 PROFUND ADVISORS LLC 0.06% 158,462 $1.5M
16 BENDER ROBERT & ASSOCIATES 0.05% 23,710 $226K
17 BHK Investment Advisors, LLC 0.05% 15,000 $143K
18 NAVELLIER & ASSOCIATES INC 0.04% 45,286 $431K
19 Inspire Investing, LLC 0.04% 53,879 $513K
20 AlphaQuest LLC 0.03% 76,405 $596K
21 China Universal Asset Management Co., Ltd. 0.03% 44,507 $424K
22 PERSONAL CFO SOLUTIONS, LLC 0.03% 21,667 $206K
23 Cypress Wealth Services, LLC 0.03% 20,000 $190K
24 Inscription Capital, LLC 0.01% 13,496 $128K
25 E Fund Management Co., Ltd. 0.01% 44,532 $424K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — BIOCRYST PHARMACEUTICALS INC (BCRX)

What does the Smart Money Trend signal show for BCRX?

Selling streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds reduced or closed their BCRX positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for BCRX?

More sellers than buyers — 46% buying: Last quarter: 160 funds reduced or exited vs 138 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for BCRX holders?

Strong quality — 35% AUM from major funds: 38 of 260 holders rank in the top 100 by AUM, accounting for 35% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held BCRX?

62% of holders stayed for 2+ years: 162 out of 260 hedge funds have held BCRX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.